LETO, Gaetano
 Distribuzione geografica
Continente #
NA - Nord America 6.739
EU - Europa 3.937
AS - Asia 3.337
SA - Sud America 469
AF - Africa 116
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.609
Nazione #
US - Stati Uniti d'America 6.637
SG - Singapore 1.249
RU - Federazione Russa 1.036
CN - Cina 877
IT - Italia 801
FI - Finlandia 447
BR - Brasile 378
DE - Germania 338
HK - Hong Kong 323
UA - Ucraina 305
VN - Vietnam 297
PL - Polonia 219
GB - Regno Unito 183
FR - Francia 168
IE - Irlanda 146
JP - Giappone 140
SE - Svezia 102
IN - India 98
KR - Corea 61
CA - Canada 50
BD - Bangladesh 46
TR - Turchia 43
EG - Egitto 39
AR - Argentina 34
IQ - Iraq 30
RO - Romania 30
BE - Belgio 29
MX - Messico 27
ES - Italia 25
NL - Olanda 25
IR - Iran 24
CI - Costa d'Avorio 21
AT - Austria 19
UZ - Uzbekistan 17
ZA - Sudafrica 17
MY - Malesia 14
NP - Nepal 14
PK - Pakistan 14
VE - Venezuela 14
CL - Cile 12
CZ - Repubblica Ceca 12
MA - Marocco 12
PH - Filippine 12
SA - Arabia Saudita 11
CH - Svizzera 9
JO - Giordania 9
LT - Lituania 9
ID - Indonesia 8
AZ - Azerbaigian 7
EC - Ecuador 7
JM - Giamaica 7
KE - Kenya 7
KZ - Kazakistan 7
TW - Taiwan 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BO - Bolivia 6
CO - Colombia 6
DZ - Algeria 6
PA - Panama 6
PT - Portogallo 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
ET - Etiopia 4
GR - Grecia 4
IL - Israele 4
LB - Libano 4
RS - Serbia 4
UY - Uruguay 4
BH - Bahrain 3
BY - Bielorussia 3
EU - Europa 3
GE - Georgia 3
HN - Honduras 3
SV - El Salvador 3
TN - Tunisia 3
AL - Albania 2
BG - Bulgaria 2
CR - Costa Rica 2
HU - Ungheria 2
NO - Norvegia 2
PE - Perù 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
CG - Congo 1
CY - Cipro 1
GM - Gambi 1
GP - Guadalupe 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MU - Mauritius 1
Totale 14.603
Città #
Singapore 872
Ashburn 823
Chandler 573
Fairfield 523
San Jose 361
Woodbridge 352
Hong Kong 303
Ann Arbor 270
Dallas 265
Wilmington 262
Houston 239
Palermo 236
Seattle 207
Cambridge 202
Moscow 193
Zgierz 171
Jacksonville 156
Beijing 150
Dublin 146
Tokyo 131
Medford 128
New York 117
Frankfurt am Main 107
Des Moines 106
Council Bluffs 103
Los Angeles 97
Santa Clara 97
Ho Chi Minh City 96
Princeton 83
Lauterbourg 80
The Dalles 78
Hanoi 71
Altamura 68
Boardman 63
Nanjing 60
Helsinki 57
Lawrence 54
San Diego 49
Buffalo 48
Milan 46
Jinan 44
Hefei 43
Tulsa 40
São Paulo 38
Orem 36
Tianjin 32
Shenyang 31
Nanchang 30
Brussels 29
Chennai 28
Chicago 26
Dearborn 26
Guangzhou 26
London 26
Munich 26
Changsha 25
Ludwigshafen am Rhein 23
Hebei 22
Warsaw 22
Abidjan 21
Cairo 20
Montreal 20
Atlanta 19
Rome 19
Denver 18
Columbus 17
Naples 17
Turku 17
Phoenix 16
Seoul 16
Haiphong 15
Jiaxing 14
Johannesburg 14
Ningbo 14
Stockholm 14
Zhengzhou 14
Da Nang 13
Kumar 13
Manchester 13
Poplar 13
Washington 13
Izmir 12
Mumbai 12
Rio de Janeiro 12
Saint Petersburg 12
Tashkent 12
Amsterdam 11
Ankara 11
Cardiff 11
City of London 11
Istanbul 11
Bagheria 10
Boston 10
Lublin 10
Shanghai 10
Tehran 10
Amman 9
Auburn Hills 9
Baghdad 9
Brooklyn 9
Totale 9.167
Nome #
Effects of Oleuropein on colon cancer progression in vitro. A preliminary report 375
Cathepsin L in metastatic bone disease: therapeutic implications 316
3,5-DIIODO-L-THYRONINE-INDUCED MODIFICATION IN PITUITARY-THYROID AXIS IN RATS FED HIGH-FAT DIET. A PRELIMINARY REPORT 310
Activin A circulating levels in patients with bone metastasis from breast or prostate cancer 297
Different Behaviour of Plasma Antioxidant Status after Red Wine Consumption in Subjects of the Same Sex: A Preliminary Report 273
Vitamin D in cancer chemoprevention 271
Cathepsin D expression levels in nongynecological solid tumors: Clinical and therapeutic implications 268
Follistatin as potential therapeutic target in prostate cancer 264
Effects of 3,5-diiodo-L-thyronine on the liver of high fat diet fed rats 263
Circulating cathepsin K and cystatin C in patients with cancer related bone disease: Clinical and therapeutic implications 262
The role of histamine in doxorubicin and teniposide-induced cardiotoxicity in dog and mouse 261
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers 259
MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone. 245
Influence of quercetin and luteolin on the activity of the catalase: study ex vivo about erythrocytes in smokers and non-smokers 241
Flavonols and flavan-3-ols as modulators of xanthine oxidase and manganese superoxide dismutase activity 225
Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report 223
Cathepsin L in normal and pathological bone reodeling 221
Serum follistatin in patients with prostate cancer metastatic to the bone 206
Effects of zoledronic acid on proteinase plasma levels in patients with bone metastases. 205
Activin A and bone metastasis 198
Activin A and matrix metalloproteinase -2 and -9 blood levels as gauges of bone metastatic spread 196
The Role of Vitamin K in Bone Remodeling and Osteoporosis 196
On the role of cystatin C in cancer progression 195
Serum interleukin-6 in patients with metastatic bone disease: correlation with cystatin C. 194
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracycline 193
Current status and future directions in the treatment of bone metastases from breast cancer 192
Effect of extra virgin olive oli phenols on HL60 cell lines sensitive and resistant to anthracyclines 191
Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma 190
Activin A circulating levels in patients with osteoporosis or bone metastasis from breast cancer 189
ACTIVIN A CIRCULATING LEVELS IN PATIENTS WITH PRIMARY OSTEOPOROSIS OR BONE METASTASES FROM BREAST CANCER 187
Adipokines in obesity and metabolic diseases 186
Effects of extra virgin olive oil phenols on HL60 cell lines sensitive and resistant to anthracyclines 183
Differential expression levels of urokinase-type plasminogen activator and cathepsin D in locally advanced laryngeal squamous cell carcinoma: Clinical implications 182
Induction of differentiation by phenols crude extract of extravirgin olive oil on tumor cell lines sensitive and resistatnt to antitumor agents 181
Cathepsin D, B and L circulating levels as prognostic markers of malignant progression 179
Activin A circulating levels in Patients with primary osteoporosis or bone metastases from brest cancer 178
Effects of oleuropein on tumor cell growth and bone remodelling: Potential clinical implications for the prevention and treatment of malignant bone diseases 178
Effects of Zoledronic Acid on Cathepsin K circulating levels in patients with bone metastasis. 176
ERYTHROCYTE CATALASE ACTIVITY IN EVER-SMOKERS AND NO-SMOKERS HEALTHY SUBJECTS: INFLUENCE OF FLAVONOIDS (QUERCETIN AND LUTEOLIN) 173
Studio del pattern di distribuzione dell'Activina A nel siero di pazienti con metastasi ossee da carcinoma prostatico in trattamento con acido zoledronico 172
TP53 mutations and S-Phase fraction are independent prognostic indicators in locally advanced laryngeal squamous cell carcinoma 172
Lenograstim in preventing chemotherapy-induced febrile neutropenia in patients with soft tissue sarcoma 172
New potential circulating markers for the therapeutic monitoring of metastatic bone disease. 171
Cytotoxic effects of a crude extract of extra virgin olive oil on human HL60 cell lines sensitive and resistant with MDR phenotype 171
Cytotoxic effects of polyphenols from waste-water of extra virgin olive oil on human HL60 and K562 cell lines. 165
Haemopoietic effects of 7 alpha, 17 beta Dimethyltestosterone 161
Activin a and matrix metalloproteinase-2 and -9 blood levels as gauges of bone metastatic spread. In: Tumor microenvironment:Heterotypic interactions. 158
Effects of phenols of extra virgin olive oil on HL60 cell lines sensitive and reristant to anthracyclines 156
Cathepsin D in the malignant progression of neoplastic diseases 152
Bioactive effects of citrus flavonoids and role in the prevention of atherosclerosis and cancer 151
Nutrition, obesity and hormones 151
Effects of phenols of extra vergin olive oil on Hl60 cell lines sensitive and resistant to anthracycline 148
Cathepsin D content in colorectal cancer 148
Cathepsin D activity levels in colorectal cancer: Correlation with cathepsin B and L and other biological and clinical parameters 146
Modulating activity of dietary flavonols and flavan-3ols on the enzymes xanthina oxidase (XO) and mitochondrial superoxide dismutase (Mn-SOD) 144
Effects of E-64 (cysteine-proteinase inhibitor) and Pepstatin (aspartyl-proteinase inhibitor) on metastasis formation in mice with mammary and ovarian tumors 143
Kinetics of in vivo inhibition of tissue cathepsin d by pepstatin A 143
Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer. 142
Acute myocardial effects of mitoxantrone in the rabbit 142
Lysosomal Cathepsins B and L and Stef in A Blood Levels in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis: Potential Clinical Implications 141
Cathepsin D: A possible biochemical marker for anthracycline cardiomyopathy 136
Antimetastatic activity of adriamycin in combinations with proteinase inhibitors in mice 135
Prognostic significance of DNA ploidy, S-phase fraction, and tissue levels of aspartic, cysteine, and serine proteases in operable gastric carcinoma 133
The potential of cystatin C as a predictive biomarker in breast cancer 133
Cathepsin D Serum Mass Concentrations in Patients with Hepatocellular Carcinoma and/or Liver Cirrhosis 133
Lysosomal alterations in heart and liver of mice treated with doxorubicin 132
Influence of flavonoids on the transmembrane electron transport:study ex-vivo 129
Effects of amsacrine (m-AMSA) a new aminoacridine antitumor drug, on the rabbit heart 127
Zoledronic acid-induced variations in MMP-2, MMP-9 and uPA plasma concentrations in patients with metastatic bone disease 125
Clinical significance of Activin A serum levels in patients with primary osteoporosis: a preliminary report 124
Induction of differentiation by phenols crude extract of extavirgin olive oil on tumor cell lines sensitive and resistant to anticancer drugs 122
Effects of extra virgin olive oil phenols on HL60 cell lines sensitve and resistant to anthracycline 121
Effects of eztra virgin olive oil phenols on HL60 cell line sensitive and resistant to anthracycline. 121
Biological characterization of laryngeal squamous-cell carcinoma 121
Selenium and Autoimmune Thyroiditis 118
Flow cytometric DNA analysis and lysosomal cathepsins b and l in locally advanced laryngeal cancer. Relationship with clinicopathologic parameters and prognostic significance 117
Stefin A and cathepsin B and L circulating serum levels in patients with malignant or non-malignant liver diseases: A preliminary report 104
Physyological role of t-PMET in erythrocytes redox homeostasis: influence of flavonoids 98
Lysosomal aspartic and cysteine proteinases serum levels in patients with pancreatic cancer or pancreatitis 93
Prevalence of hepatic steatosis in patients with type 2 diabetes and response to glucose-lowering treatments. A multicenter retrospective study in Italian specialist care 92
Transposition of cardiovascular outcome trial effects to the real-world population of patients with type 2 diabetes 91
LIVELLI CIRCOLANTI DI ACTIVINA A IN PAZIENTI CON OSTEOPOROSI PRIMITIVA O METASTASI OSSEE DA CARCINOMA MAMMARIO 90
Pepstatins: Aspartic proteinase inhibitors having potential therapeutic applications 89
Characterization of the metastatic properties of two methylcholantrene-induced fibrosarcoma in mice 83
Membrane gangliosides and immuno-mediated cytolysis in drug sensitive and treatment-induced multidrug resistant human ovarian cancer cells 71
Tumor markers in urogynaecological tumors. 68
null 59
null 47
null 3
Totale 14.986
Categoria #
all - tutte 47.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.746


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021199 0 0 0 0 0 0 0 0 0 0 87 112
2021/20221.026 50 230 9 47 40 39 41 55 140 150 41 184
2022/20231.432 150 238 53 176 130 257 84 111 143 11 45 34
2023/2024722 34 96 49 55 63 119 56 65 21 36 33 95
2024/20251.648 36 79 98 194 74 74 113 116 98 179 240 347
2025/20265.836 466 147 500 500 597 909 829 559 435 708 186 0
Totale 14.986